Article in ACS chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Samuel TanoeyadiDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331-3507 United States.
Wei ZhouDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331-3507 United States.ORCID 0000-0001-7540-2459
Andrew R OsbornDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331-3507 United States.
Takeshi TsunodaDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331-3507 United States.ORCID 0000-0002-4374-7863
Arash SamadiDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331-3507 United States.
Sachin BuradeDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331-3507 United States.
Ty J WaldoDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331-3507 United States.
Melanie A HigginsDepartment of Biological Sciences, The University of Alabama, Tuscaloosa, Alabama 35487 United States.
Taifo MahmudDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331-3507 United States.ORCID 0000-0001-9639-526X
Funding
Research Training in Natural Product Complementary and Integrative Health - Diversity Supplement to T32 Predoctoral Training GrantT32AT010131 · NCCIH · OREGON STATE UNIVERSITY · PI TAIFO MAHMUD, RICHARD B VAN BREEMEN · 2020 to 2026
$1.8M
Biosynthetic studies and development of ribomimetic-based anti-infectivesR01AI129957 · NIAID · OREGON STATE UNIVERSITY · PI MAHMUD, TAIFO · 2018 to 2022
$1.8M
Investigating biosynthetic enzymes to enhance natural product discoveryR35GM151137 · NIGMS · UNIVERSITY OF ALABAMA IN TUSCALOOSA · PI Melanie Ann Higgins · 2023 to 2026
$1.4M
Biochemical and Mechanistic Studies of PseudoglycosyltransferasesR15GM112068 · NIGMS · OREGON STATE UNIVERSITY · PI MAHMUD, TAIFO · 2014 to 2014
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.